iralukast



iralukast

O S O O O H O O H F F F O O H

SMILES CCCc1c(OCCCC/C=C\C=C\[C@H](Sc2ccc3c(=O)cc(C(=O)O)oc3c2)[C@H](O)c2cccc(C(F)(F)F)c2)ccc(C(C)=O)c1O
InChIKey IXJCHVMUTFCRBH-SDUHDBOFSA-N

Chemical Properties

Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 16
Molecular weight (Da) 710.2


Bioactivities

iralukast

O S O O O H O O H F F F O O H

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV


Compound is not listed as a drug.